NCT02965495

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

A Multicenter, Randomized, Double-blinded, Parallel, Placebo-controlled, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of Intra-articular YYD302 Once in the Treatment of Patients With Osteoarthritis of the Knee

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Yooyoung Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Accepted

Summary

This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YYD302 for treatment of osteoarthritis of the knee.

Detailed description

phase I/IIa clinical trial of YYD302 for treatment of osteoarthritis of the knee

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DRUG	YYD302 2ml	YYD302 2ml
DRUG	YYD302 3ml	YYD302 3ml
DRUG	Placebo 3ml	phosphate buffered saline 3ml

Timeline

• Start date: 2016-11-01
• Primary completion: 2017-09-01
• Completion: 2017-09-01
• First posted: 2016-11-16
• Last updated: 2017-12-11

Locations

1 site across 1 country: South Korea